Wespac Advisors, LLC Moderna, Inc. Transaction History

Wespac Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$225.82 - $368.51 $386,829 - $631,257	-1,713 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$221.9 - $484.47 $380,114 - $829,897	1,713 New	1,713 $659,000
Q2 2021 Aug 03, 2021	SELL	$129.91 - $234.98 $280,735 - $507,791	-2,161 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $235,937 - $401,902	2,161 New	2,161 $283,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors, LLC with notifications on news.